{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:11:53Z","timestamp":1760573513108,"version":"build-2065373602"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Zhejiang Provincial Natural Science Foundation of China","award":["LY24H020008"],"award-info":[{"award-number":["LY24H020008"]}]},{"name":"the Key Research and Development Program of Zhejiang Province","award":["2023C03018"],"award-info":[{"award-number":["2023C03018"]}]},{"name":"the Public Welfare Science and Technology Plan Project of Wenzhou City","award":["Y2020925"],"award-info":[{"award-number":["Y2020925"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00394-025-03799-3","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T07:56:43Z","timestamp":1758182203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Xanthohumol exerts protective function on adriamycin-induced podocyte injury"],"prefix":"10.1007","volume":"64","author":[{"given":"Huihui","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rengcheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinjuan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0261-4749","authenticated-orcid":false,"given":"Dexuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"issue":"1","key":"3799_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.26574\/maedica.2022.17.1.153","volume":"17","author":"RM Busuioc","year":"2022","unstructured":"Busuioc RM, Mircescu G (2022) Nephrotic syndrome complications: new and old. Part 1. Maedica (Bucur) 17(1):153\u2013168. https:\/\/doi.org\/10.26574\/maedica.2022.17.1.153","journal-title":"Maedica (Bucur)"},{"key":"3799_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2021.08.001","volume":"108","author":"I Kostovska","year":"2022","unstructured":"Kostovska I, Trajkovska KT, Topuzovska S, Cekovska S, Labudovic D, Kostovski O, Spasovski G (2022) Nephrinuria and podocytopathies. Adv Clin Chem 108:1\u201336. https:\/\/doi.org\/10.1016\/bs.acc.2021.08.001","journal-title":"Adv Clin Chem"},{"issue":"7","key":"3799_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.31083\/j.fbl2907250","volume":"29","author":"S Husain","year":"2024","unstructured":"Husain S (2024) Role of podocyte in kidney disease. Front Biosci (Landmark Ed) 29(7):250. https:\/\/doi.org\/10.31083\/j.fbl2907250","journal-title":"Front Biosci (Landmark Ed)"},{"key":"3799_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.915153","volume":"13","author":"Y Feng","year":"2022","unstructured":"Feng Y, Li M, Wang Y, Yang M, Shi G, Yin D, Xuan Z, Xu F (2022) Activation of TRPC6 by Ang\u2161 induces podocyte injury and participates in proteinuria of nephrotic syndrome. Front Pharmacol 13:915153. https:\/\/doi.org\/10.3389\/fphar.2022.915153","journal-title":"Front Pharmacol"},{"issue":"10","key":"3799_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41419-021-04156-y","volume":"12","author":"Z Lu","year":"2021","unstructured":"Lu Z, Liu H, Song N, Liang Y, Zhu J, Chen J, Ning Y, Hu J, Fang Y, Teng J, Zou J, Dai Y, Ding X (2021) METTL14 aggravates podocyte injury and glomerulopathy progression through N(6)-methyladenosine-dependent downregulating of Sirt1. Cell Death Dis 12(10):881. https:\/\/doi.org\/10.1038\/s41419-021-04156-y","journal-title":"Cell Death Dis"},{"issue":"1","key":"3799_CR6","doi-asserted-by":"publisher","first-page":"12297","DOI":"10.1038\/s41598-022-16333-w","volume":"12","author":"S Jeruschke","year":"2022","unstructured":"Jeruschke S, Alex D, Hoyer PF, Weber S (2022) Protective effects of rituximab on puromycin-induced apoptosis, loss of adhesion and cytoskeletal alterations in human podocytes. Sci Rep 12(1):12297. https:\/\/doi.org\/10.1038\/s41598-022-16333-w","journal-title":"Sci Rep"},{"issue":"10","key":"3799_CR7","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1172\/JCI140155","volume":"130","author":"A Chen","year":"2020","unstructured":"Chen A, Feng Y, Lai H, Ju W, Li Z, Li Y, Wang A, Hong Q, Zhong F, Wei C, Fu J, Guan T, Liu B, Kretzler M, Lee K, He JC (2020) Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression. J Clin Invest 130(10):5523\u20135535. https:\/\/doi.org\/10.1172\/JCI140155","journal-title":"J Clin Invest"},{"key":"3799_CR8","doi-asserted-by":"publisher","unstructured":"Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S, Wetzels J, Alhasan K, Banerjee S, Bhimma R, Bonilla-Felix M, Cano F, Christian M, Hahn D, Kang HG, Nakanishi K, Safouh H, Trachtman H, Xu H, Cook W, Vivarelli M, Haffner D, International Pediatric Nephrology A (2023) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 38 (3):877\u2013919. https:\/\/doi.org\/10.1007\/s00467-022-05739-3","DOI":"10.1007\/s00467-022-05739-3"},{"issue":"3","key":"3799_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10157-020-01854-3","volume":"24","author":"H Kawachi","year":"2020","unstructured":"Kawachi H, Fukusumi Y (2020) New insight into podocyte slit diaphragm, a therapeutic target of proteinuria. Clin Exp Nephrol 24(3):193\u2013204. https:\/\/doi.org\/10.1007\/s10157-020-01854-3","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"3799_CR10","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","volume":"89","author":"M Nagata","year":"2016","unstructured":"Nagata M (2016) Podocyte injury and its consequences. Kidney Int 89(6):1221\u20131230. https:\/\/doi.org\/10.1016\/j.kint.2016.01.012","journal-title":"Kidney Int"},{"issue":"1","key":"3799_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2314637","volume":"46","author":"N Yu","year":"2024","unstructured":"Yu N, Ouyang X, Li J, Gao J, Zeng S, Zhuang H, Jiang M, Pei Y, Jiang X (2024) Risk factors and renal outcomes of AKI in children with secondary steroid-resistant nephrotic syndrome. Ren Fail 46(1):2314637. https:\/\/doi.org\/10.1080\/0886022X.2024.2314637","journal-title":"Ren Fail"},{"key":"3799_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.crphys.2021.12.004","volume":"5","author":"R Varghese","year":"2022","unstructured":"Varghese R, Majumdar A (2022) A new prospect for the treatment of nephrotic syndrome based on network pharmacology analysis. Curr Res Physiol 5:36\u201347. https:\/\/doi.org\/10.1016\/j.crphys.2021.12.004","journal-title":"Curr Res Physiol"},{"issue":"4","key":"3799_CR13","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1046\/j.1523-1755.2000.00342.x","volume":"58","author":"Y Wang","year":"2000","unstructured":"Wang Y, Wang YP, Tay YC, Harris DC (2000) Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int 58(4):1797\u20131804. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00342.x","journal-title":"Kidney Int"},{"issue":"5","key":"3799_CR14","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.3892\/etm.2018.5933","volume":"15","author":"YP Sai","year":"2018","unstructured":"Sai YP, Song YC, Chen XX, Luo X, Liu J, Cui WJ (2018) Protective effect of astragalosides from Radix Astragali on adriamycin-induced podocyte injury. Exp Ther Med 15(5):4485\u20134490. https:\/\/doi.org\/10.3892\/etm.2018.5933","journal-title":"Exp Ther Med"},{"key":"3799_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112789","volume":"257","author":"XW Wang","year":"2020","unstructured":"Wang XW, Tian RM, Yang YQ, Wang K, Li EN, Han XD, Bao K, Mao W, Xu HT, Liu B, Xu P (2020) Tripterygium glycoside fraction n2 ameliorates adriamycin-induced nephrotic syndrome in rats by suppressing apoptosis. J Ethnopharmacol 257:112789. https:\/\/doi.org\/10.1016\/j.jep.2020.112789","journal-title":"J Ethnopharmacol"},{"key":"3799_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154736","volume":"113","author":"Z Ai","year":"2023","unstructured":"Ai Z, Wang M, Zhou Y, Yuan D, Jian Q, Wu S, Liu B, Yang Y (2023) Deciphering the pharmacological mechanisms of Rostellularia procumbens (L) Nees. extract alleviates adriamycin-induced nephropathy in vivo and in vitro. Phytomedicine 113:154736. https:\/\/doi.org\/10.1016\/j.phymed.2023.154736","journal-title":"Phytomedicine"},{"issue":"Pt B","key":"3799_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2022.134629","volume":"404","author":"V de Andrade","year":"2023","unstructured":"de Andrade V, Silva G, Demaman Arend G, Antonio Ferreira Zielinski A, Di Luccio M, Ambrosi A (2023) Xanthohumol properties and strategies for extraction from hops and brewery residues: a review. Food Chem 404(Pt B):134629. https:\/\/doi.org\/10.1016\/j.foodchem.2022.134629","journal-title":"Food Chem"},{"key":"3799_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.redox.2017.03.001","volume":"12","author":"H Lv","year":"2017","unstructured":"Lv H, Liu Q, Wen Z, Feng H, Deng X, Ci X (2017) Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK\/GSK3beta-Nrf2 signal axis. Redox Biol 12:311\u2013324. https:\/\/doi.org\/10.1016\/j.redox.2017.03.001","journal-title":"Redox Biol"},{"issue":"9","key":"3799_CR19","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/jpp\/rgab052","volume":"73","author":"XL Sun","year":"2021","unstructured":"Sun XL, Zhang JB, Guo YX, Xia TS, Xu LC, Rahmand K, Wang GP, Li XJ, Han T, Wang NN, Xin HL (2021) Xanthohumol ameliorates memory impairment and reduces the deposition of beta-amyloid in APP\/PS1 mice via regulating the mTOR\/LC3II and Bax\/Bcl-2 signalling pathways. J Pharm Pharmacol 73(9):1230\u20131239. https:\/\/doi.org\/10.1093\/jpp\/rgab052","journal-title":"J Pharm Pharmacol"},{"key":"3799_CR20","doi-asserted-by":"publisher","first-page":"1105726","DOI":"10.3389\/fphar.2023.1105726","volume":"14","author":"Y Huangfu","year":"2023","unstructured":"Huangfu Y, Yu X, Wan C, Zhu Y, Wei Z, Li F, Wang Y, Zhang K, Li S, Dong Y, Li Y, Niu H, Xin G, Huang W (2023) Xanthohumol alleviates oxidative stress and impaired autophagy in experimental severe acute pancreatitis through inhibition of AKT\/mTOR. Front Pharmacol 14:1105726. https:\/\/doi.org\/10.3389\/fphar.2023.1105726","journal-title":"Front Pharmacol"},{"key":"3799_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.intimp.2018.05.017","volume":"61","author":"F Li","year":"2018","unstructured":"Li F, Yao Y, Huang H, Hao H, Ying M (2018) Xanthohumol attenuates cisplatin-induced nephrotoxicity through inhibiting NF-kappaB and activating Nrf2 signaling pathways. Int Immunopharmacol 61:277\u2013282. https:\/\/doi.org\/10.1016\/j.intimp.2018.05.017","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"3799_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s11418-024-01863-6","volume":"79","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Pan R, Shou Z, Zhao Y (2025) Xanthohumol attenuates TXNIP-mediated renal tubular injury in vitro and in vivo diabetic models. J Nat Med 79(2):314\u2013327. https:\/\/doi.org\/10.1007\/s11418-024-01863-6","journal-title":"J Nat Med"},{"key":"3799_CR23","doi-asserted-by":"publisher","first-page":"174480692312040","DOI":"10.1177\/17448069231204051","volume":"19","author":"Q Wang","year":"2023","unstructured":"Wang Q, Chen T, Shuqing Z, Yu L, Chen S, Lu H, Zhu H, Min X, Li X, Liu L (2023) Xanthohumol relieves arthritis pain in mice by suppressing mitochondrial-mediated inflammation. Mol Pain 19:17448069231204052. https:\/\/doi.org\/10.1177\/17448069231204051","journal-title":"Mol Pain"},{"issue":"6","key":"3799_CR24","doi-asserted-by":"publisher","first-page":"548","DOI":"10.12047\/j.cjap.5879.2019.120","volume":"35","author":"YH Tang","year":"2019","unstructured":"Tang YH, Yin CZ, Li K, Li WX, Fan CF (2019) Protective effects of azithromycin on adriamycin-induced nephropathy with albumin overload in mice. Zhongguo ying yong sheng li xue za zhi=Zhongguo yingyong shenglixue zazhi=Chinese J Appl Physiol 35(6):548\u2013550. https:\/\/doi.org\/10.12047\/j.cjap.5879.2019.120","journal-title":"Zhongguo ying yong sheng li xue za zhi=Zhongguo yingyong shenglixue zazhi=Chinese J Appl Physiol"},{"issue":"1","key":"3799_CR25","doi-asserted-by":"publisher","first-page":"F74","DOI":"10.1152\/ajprenal.00114.2017","volume":"313","author":"M Yi","year":"2017","unstructured":"Yi M, Zhang L, Liu Y, Livingston MJ, Chen JK, Nahman NS Jr., Liu F, Dong Z (2017) Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy. Am J Physiol Renal Physiol 313(1):F74\u2013F84. https:\/\/doi.org\/10.1152\/ajprenal.00114.2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"3799_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.837828","volume":"10","author":"J Van de Leemput","year":"2022","unstructured":"Van de Leemput J, Wen P, Han Z (2022) Using Drosophila nephrocytes to understand the formation and maintenance of the podocyte slit diaphragm. Front Cell Dev Biol 10:837828. https:\/\/doi.org\/10.3389\/fcell.2022.837828","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"3799_CR27","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1681\/ASN.2015080896","volume":"27","author":"H Yu","year":"2016","unstructured":"Yu H, Kistler A, Faridi MH, Meyer JO, Tryniszewska B, Mehta D, Yue L, Dryer S, Reiser J (2016) Synaptopodin limits TRPC6 podocyte surface expression and attenuates proteinuria. J Am Soc Nephrol 27(11):3308\u20133319. https:\/\/doi.org\/10.1681\/ASN.2015080896","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"3799_CR28","doi-asserted-by":"publisher","first-page":"12047","DOI":"10.1038\/s41598-017-12134-8","volume":"7","author":"A Sagar","year":"2017","unstructured":"Sagar A, Arif E, Solanki AK, Srivastava P, Janech MG, Kim SH, Lipschutz JH, Kwon SH, Ashish ND (2017) Targeting Neph1 and ZO-1 protein-protein interaction in podocytes prevents podocyte injury and preserves glomerular filtration function. Sci Rep 7(1):12047. https:\/\/doi.org\/10.1038\/s41598-017-12134-8","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"3799_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.etp.2010.06.004","volume":"64","author":"A Herrmann","year":"2012","unstructured":"Herrmann A, Tozzo E, Funk J (2012) Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model. Exp Toxicol Pathol 64(1\u20132):45\u201349. https:\/\/doi.org\/10.1016\/j.etp.2010.06.004","journal-title":"Exp Toxicol Pathol"},{"issue":"5","key":"3799_CR30","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1681\/ASN.2020040501","volume":"32","author":"A Moller-Kerutt","year":"2021","unstructured":"Moller-Kerutt A, Rodriguez-Gatica JE, Wacker K, Bhatia R, Siebrasse JP, Boon N, Van Marck V, Boor P, Kubitscheck U, Wijnholds J, Pavenstadt H, Weide T (2021) Crumbs2 is an essential slit diaphragm protein of the renal filtration barrier. J Am Soc Nephrol 32(5):1053\u20131070. https:\/\/doi.org\/10.1681\/ASN.2020040501","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"3799_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ajhg.2014.11.014","volume":"96","author":"L Ebarasi","year":"2015","unstructured":"Ebarasi L, Ashraf S, Bierzynska A, Gee HY, McCarthy HJ, Lovric S, Sadowski CE, Pabst W, Vega-Warner V, Fang H, Koziell A, Simpson MA, Dursun I, Serdaroglu E, Levy S, Saleem MA, Hildebrandt F, Majumdar A (2015) Defects of CRB2 cause steroid-resistant nephrotic syndrome. Am J Hum Genet 96(1):153\u2013161. https:\/\/doi.org\/10.1016\/j.ajhg.2014.11.014","journal-title":"Am J Hum Genet"},{"issue":"1","key":"3799_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/cge.14222","volume":"103","author":"M Adutwum","year":"2023","unstructured":"Adutwum M, Hurst A, Mirzaa G, Kushner JD, Rogers C, Khalek N, Cristancho AG, Burrill N, Seifert ME, Scarano MI, Schnur RE, Slavotinek A (2023) Six new cases of CRB2-related syndrome and a review of clinical findings in 28 reported patients. Clin Genet 103(1):97\u2013102. https:\/\/doi.org\/10.1111\/cge.14222","journal-title":"Clin Genet"},{"issue":"11","key":"3799_CR33","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1007\/s00467-023-06042-5","volume":"38","author":"A Kaur","year":"2023","unstructured":"Kaur A, Banday AZ, Dawman L, Rawat A, Tiewsoh K (2023) Factors predicting the occurrence of disease-causing variants on next-generation sequencing in children with steroid-resistant nephrotic syndrome - implications for resource-constrained settings. Pediatr Nephrol 38(11):3663\u20133670. https:\/\/doi.org\/10.1007\/s00467-023-06042-5","journal-title":"Pediatr Nephrol"},{"key":"3799_CR34","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2022010070","author":"I Hada","year":"2022","unstructured":"Hada I, Shimizu A, Takematsu H, Nishibori Y, Kimura T, Fukutomi T, Kudo A, Ito-Nitta N, Kiuchi Z, Patrakka J, Mikami N, Leclerc S, Akimoto Y, Hirayama Y, Mori S, Takano T, Yan K (2022) A novel mouse model of idiopathic nephrotic syndrome induced by immunization with the podocyte protein Crb2. J Am Soc Nephrol. https:\/\/doi.org\/10.1681\/ASN.2022010070","journal-title":"J Am Soc Nephrol"},{"issue":"29","key":"3799_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308556","volume":"11","author":"G Wang","year":"2024","unstructured":"Wang G, Wu H, Zhai X, Zhang L, Zhang C, Cheng C, Xu X, Gao E, Xiong X, Zhang J, Liu Z (2024) Kidney organoid modeling of WT1 mutations reveals key regulatory paths underlying podocyte development. Adv Sci (Weinh) 11(29):e2308556. https:\/\/doi.org\/10.1002\/advs.202308556","journal-title":"Adv Sci (Weinh)"},{"key":"3799_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.biopha.2017.09.105","volume":"96","author":"R Lu","year":"2017","unstructured":"Lu R, Zhou J, Liu B, Liang N, He Y, Bai L, Zhang P, Zhong Y, Zhou Y, Zhou J (2017) Paeoniflorin ameliorates Adriamycin-induced nephrotic syndrome through the PPARgamma\/ANGPTL4 pathway in vivo and vitro. Biomed Pharmacother 96:137\u2013147. https:\/\/doi.org\/10.1016\/j.biopha.2017.09.105","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"3799_CR37","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S2352-4642(18)30283-9","volume":"2","author":"K Tullus","year":"2018","unstructured":"Tullus K, Webb H, Bagga A (2018) Management of steroid-resistant nephrotic syndrome in children and adolescents. Lancet Child Adolesc Health 2(12):880\u2013890. https:\/\/doi.org\/10.1016\/S2352-4642(18)30283-9","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"3799_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/s0014-5793(01)02210-4","volume":"491","author":"M Yilmazer","year":"2001","unstructured":"Yilmazer M, Stevens JF, Buhler DR (2001) In vitro glucuronidation of xanthohumol, a flavonoid in hop and beer, by rat and human liver microsomes. FEBS Lett 491(3):252\u2013256. https:\/\/doi.org\/10.1016\/s0014-5793(01)02210-4","journal-title":"FEBS Lett"},{"issue":"3","key":"3799_CR39","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/mnfr.201100554","volume":"56","author":"L Legette","year":"2012","unstructured":"Legette L, Ma L, Reed RL, Miranda CL, Christensen JM, Rodriguez-Proteau R, Stevens JF (2012) Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration. Mol Nutr Food Res 56(3):466\u2013474. https:\/\/doi.org\/10.1002\/mnfr.201100554","journal-title":"Mol Nutr Food Res"},{"issue":"10","key":"3799_CR40","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/mnfr.201400245","volume":"58","author":"RB van Breemen","year":"2014","unstructured":"van Breemen RB, Yuan Y, Banuvar S, Shulman LP, Qiu X, Alvarenga RF, Chen SN, Dietz BM, Bolton JL, Pauli GF, Krause E, Viana M, Nikolic D (2014) Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hops. Mol Nutr Food Res 58(10):1962\u20131969. https:\/\/doi.org\/10.1002\/mnfr.201400245","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"3799_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/bdd.2306","volume":"43","author":"HH Bai","year":"2022","unstructured":"Bai HH, Xia TS, Jiang YP, Xu WM, Xu PC, Wang NN, Gou XJ, Xin HL (2022) Absorption, metabolism, and pharmacokinetic profile of xanthohumol in rats as determined via UPLC-MS\/MS. Biopharm Drug Dispos 43(1):11\u201322. https:\/\/doi.org\/10.1002\/bdd.2306","journal-title":"Biopharm Drug Dispos"},{"issue":"6","key":"3799_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202100831","volume":"66","author":"HF Neumann","year":"2022","unstructured":"Neumann HF, Frank J, Venturelli S, Egert S (2022) Bioavailability and cardiometabolic effects of xanthohumol: evidence from animal and human studies. Mol Nutr Food Res 66(6):e2100831. https:\/\/doi.org\/10.1002\/mnfr.202100831","journal-title":"Mol Nutr Food Res"},{"issue":"7","key":"3799_CR43","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.fct.2010.04.030","volume":"48","author":"C Dorn","year":"2010","unstructured":"Dorn C, Bataille F, Gaebele E, Heilmann J, Hellerbrand C (2010) Xanthohumol feeding does not impair organ function and homoeostasis in mice. Food Chem Toxicol 48(7):1890\u20131897. https:\/\/doi.org\/10.1016\/j.fct.2010.04.030","journal-title":"Food Chem Toxicol"},{"key":"3799_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00140","volume":"6","author":"R Weiskirchen","year":"2015","unstructured":"Weiskirchen R, Mahli A, Weiskirchen S, Hellerbrand C (2015) The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels. Front Physiol 6:140. https:\/\/doi.org\/10.3389\/fphys.2015.00140","journal-title":"Front Physiol"},{"issue":"8","key":"3799_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202001170","volume":"65","author":"BO Langley","year":"2021","unstructured":"Langley BO, Ryan JJ, Hanes D, Phipps J, Stack E, Metz TO, Stevens JF, Bradley R (2021) Xanthohumol microbiome and signature in healthy adults (the XMaS trial): safety and tolerability results of a phase I triple-masked, placebo-controlled clinical trial. Mol Nutr Food Res 65(8):e2001170. https:\/\/doi.org\/10.1002\/mnfr.202001170","journal-title":"Mol Nutr Food Res"},{"key":"3799_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.727874","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Liu J, Tian R, Zheng B, Li C, Huang L, Lu Z, Zhang J, Mao W, Liu B, Bao K, Xu P (2021) Sanqi oral solution mitigates proteinuria in rat passive Heymann nephritis and blocks podocyte apoptosis via Nrf2\/HO-1 pathway. Front Pharmacol 12:727874. https:\/\/doi.org\/10.3389\/fphar.2021.727874","journal-title":"Front Pharmacol"},{"issue":"11","key":"3799_CR47","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00467-012-2376-5","volume":"28","author":"I Simic","year":"2013","unstructured":"Simic I, Tabatabaeifar M, Schaefer F (2013) Animal models of nephrotic syndrome. Pediatr Nephrol 28(11):2079\u20132088. https:\/\/doi.org\/10.1007\/s00467-012-2376-5","journal-title":"Pediatr Nephrol"},{"key":"3799_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010647","author":"S Ma","year":"2024","unstructured":"Ma S, Qiu Y, Zhang C (2024) Cytoskeleton rearrangement in podocytopathies: an update. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25010647","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3799_CR49","doi-asserted-by":"publisher","first-page":"20556","DOI":"10.1038\/s41598-021-00159-z","volume":"11","author":"A Tanoue","year":"2021","unstructured":"Tanoue A, Katayama K, Ito Y, Joh K, Toda M, Yasuma T, D\u2019Alessandro-Gabazza CN, Kawachi H, Yan K, Ito M, Gabazza EC, Tryggvason K, Dohi K (2021) Podocyte-specific Crb2 knockout mice develop focal segmental glomerulosclerosis. Sci Rep 11(1):20556. https:\/\/doi.org\/10.1038\/s41598-021-00159-z","journal-title":"Sci Rep"},{"key":"3799_CR50","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/978-981-13-8871-2_24","volume":"1165","author":"D Liu","year":"2019","unstructured":"Liu D, Lv LL (2019) New understanding on the role of proteinuria in progression of chronic kidney disease. Adv Exp Med Biol 1165:487\u2013500. https:\/\/doi.org\/10.1007\/978-981-13-8871-2_24","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"3799_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13850","volume":"235","author":"Q Ye","year":"2022","unstructured":"Ye Q, Lan B, Liu H, Persson PB, Lai EY, Mao J (2022) A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies. Acta Physiol (Oxf) 235(4):e13850. https:\/\/doi.org\/10.1111\/apha.13850","journal-title":"Acta Physiol (Oxf)"},{"key":"3799_CR52","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202201649","author":"A Moller-Kerutt","year":"2023","unstructured":"Moller-Kerutt A, Schonhoff B, Rellmann Y, George B, Braun DA, Pavenstadt H, Weide T (2023) Loss of surface transport is a main cellular pathomechanism of CRB2 variants causing podocytopathies. Life Sci Alliance. https:\/\/doi.org\/10.26508\/lsa.202201649","journal-title":"Life Sci Alliance"},{"issue":"1","key":"3799_CR53","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ajhg.2014.11.013","volume":"96","author":"A Slavotinek","year":"2015","unstructured":"Slavotinek A, Kaylor J, Pierce H, Cahr M, DeWard SJ, Schneidman-Duhovny D, Alsadah A, Salem F, Schmajuk G, Mehta L (2015) Crb2 mutations produce a phenotype resembling congenital nephrosis, finnish type, with cerebral ventriculomegaly and raised alpha-fetoprotein. Am J Hum Genet 96(1):162\u2013169. https:\/\/doi.org\/10.1016\/j.ajhg.2014.11.013","journal-title":"Am J Hum Genet"},{"issue":"7","key":"3799_CR54","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.ajpath.2021.04.004","volume":"191","author":"Y Fukusumi","year":"2021","unstructured":"Fukusumi Y, Yasuda H, Zhang Y, Kawachi H (2021) Nephrin-Ephrin-B1-Na(+)\/H(+) exchanger regulatory factor 2-Ezrin-Actin axis is critical in podocyte injury. Am J Pathol 191(7):1209\u20131226. https:\/\/doi.org\/10.1016\/j.ajpath.2021.04.004","journal-title":"Am J Pathol"},{"key":"3799_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1381479","volume":"11","author":"Y Liu","year":"2024","unstructured":"Liu Y, Ge RL, Shan ZZ, Wang YJ, Yang YY, Sun X, Luo PL (2024) Adriamycin-induced podocyte injury via the Sema3A\/TRPC5\/Rac1 pathway. Front Med Lausanne 11:1381479. https:\/\/doi.org\/10.3389\/fmed.2024.1381479","journal-title":"Front Med Lausanne"},{"key":"3799_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115617","volume":"167","author":"C Xu","year":"2023","unstructured":"Xu C, Liu X, Zhai X, Wang G, Qin W, Cheng Z, Chen Z (2023) CDDO-me ameliorates podocyte injury through anti-oxidative stress and regulation of actin cytoskeleton in adriamycin nephropathy. Biomed Pharmacother 167:115617. https:\/\/doi.org\/10.1016\/j.biopha.2023.115617","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"3799_CR57","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.1007\/s12010-023-04333-z","volume":"195","author":"B Ji","year":"2023","unstructured":"Ji B, Liu J, Ma Y, Yin Y, Xu H, Shen Q, Yu J (2023) Minnelide markedly reduces proteinuria in mice with Adriamycin nephropathy by protecting against podocyte injury. Appl Biochem Biotechnol 195(12):7379\u20137396. https:\/\/doi.org\/10.1007\/s12010-023-04333-z","journal-title":"Appl Biochem Biotechnol"},{"issue":"3","key":"3799_CR58","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2174\/1871520621666210223095021","volume":"22","author":"HS Tuli","year":"2022","unstructured":"Tuli HS, Aggarwal V, Parashar G, Aggarwal D, Parashar NC, Tuorkey MJ, Varol M, Sak K, Kumar M, Buttar HS (2022) Xanthohumol: a metabolite with promising anti-neoplastic potential. Anticancer Agents Med Chem 22(3):418\u2013432. https:\/\/doi.org\/10.2174\/1871520621666210223095021","journal-title":"Anticancer Agents Med Chem"},{"issue":"4","key":"3799_CR59","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s11033-019-05128-4","volume":"47","author":"Y Jiao","year":"2020","unstructured":"Jiao Y, Cao Y, Lu X, Wang J, Saitgareeva A, Kong X, Song C, Li J, Tian K, Zhang S, Bai M, Li S, Zhang H, Wang L (2020) Xanthohumol protects neuron from cerebral ischemia injury in experimental stroke. Mol Biol Rep 47(4):2417\u20132425. https:\/\/doi.org\/10.1007\/s11033-019-05128-4","journal-title":"Mol Biol Rep"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-025-03799-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00394-025-03799-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-025-03799-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:13:08Z","timestamp":1760501588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00394-025-03799-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3799"],"URL":"https:\/\/doi.org\/10.1007\/s00394-025-03799-3","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"type":"print","value":"1436-6207"},{"type":"electronic","value":"1436-6215"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"14 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All animal experiments are carried out in accordance with the Guide for the Use and Care of Laboratory Animals, issued by the National Institutes of Health and approved by the Animal Ethics Committee of Wenzhou Medical University (approval ID: wydw2021-0586, date: 3 December 2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"278"}}